Loading...

Moderna, Inc. Peer Comparison

Metric Value Ranking
Market Cap $11.8 Billion 2/17 VRTX
$117.2B
MRNA
$11.8B
RETA
$6.6B
KRYS
$4.4B
BEAM
$2.4B
NVAX
$1.3B
NTLA
$968.6M
CVAC
$823.2M
DNA
$708.1M
EDIT
$98.2M
ELEV
$36.7M
RAIN
$26.1M
OCEA
$5.9M
AVRO
$5.2M
ENVB
$3.0M
HEPA
$2.1M
CWBR
$1.2M
Gross Margin 72% 7/17 NTLA
100%
RETA
96%
CVAC
96%
KRYS
90%
DNA
89%
VRTX
86%
MRNA
72%
BEAM
62%
NVAX
28%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
ELEV
0%
OCEA
0%
ENVB
0%
EDIT
-100%
Profit Margin 1% 5/17 RETA
100%
CVAC
68%
VRTX
38%
KRYS
32%
MRNA
1%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
ELEV
0%
OCEA
0%
ENVB
0%
DNA
-63%
NVAX
-100%
EDIT
-100%
NTLA
-100%
BEAM
-100%
EBITDA margin -4% 4/17 CVAC
76%
VRTX
40%
KRYS
27%
MRNA
-4%
DNA
-62%
CWBR
-100%
AVRO
-100%
HEPA
-100%
RAIN
-100%
ELEV
-100%
OCEA
-100%
ENVB
-100%
NVAX
-159%
RETA
-356%
BEAM
-639%
NTLA
-1490%
EDIT
-101870%
Quarterly Revenue $1.9 Billion 2/17 VRTX
$2.8B
MRNA
$1.9B
CVAC
$542.7M
DNA
$89.0M
NVAX
$84.5M
KRYS
$83.8M
RETA
$22.7M
BEAM
$14.3M
NTLA
$9.1M
EDIT
$61,000
CWBR
$0
AVRO
$0
HEPA
$0
RAIN
$0
ELEV
$0
OCEA
$0
ENVB
$0
Quarterly Earnings $13.0 Million 5/17 VRTX
$1.0B
CVAC
$371.5M
RETA
$193.0M
KRYS
$27.2M
MRNA
$13.0M
ENVB
-$2.1M
RAIN
-$3.0M
CWBR
-$4.3M
HEPA
-$4.9M
OCEA
-$5.5M
AVRO
-$6.8M
ELEV
-$12.9M
DNA
-$56.4M
EDIT
-$62.1M
BEAM
-$96.7M
NVAX
-$121.3M
NTLA
-$135.7M
Quarterly Free Cash Flow -$1.7 Million 16/17 VRTX
$1.5B
CVAC
$385.5M
KRYS
$57.8M
OCEA
-$885,000
ENVB
-$927,073
CWBR
-$1.8M
HEPA
-$2.5M
AVRO
-$7.6M
ELEV
-$16.6M
EDIT
-$55.5M
RETA
-$70.2M
NTLA
-$86.1M
BEAM
-$89.7M
DNA
-$118.6M
NVAX
-$145.6M
MRNA
-$1.7B
RAIN
-$0
Trailing 4 Quarters Revenue $5.1 Billion 2/17 VRTX
$10.6B
MRNA
$5.1B
NVAX
$885.2M
CVAC
$596.5M
BEAM
$349.6M
KRYS
$241.5M
DNA
$218.0M
EDIT
$61.8M
NTLA
$43.1M
RETA
$24.4M
CWBR
$0
AVRO
$0
HEPA
$0
RAIN
$0
ELEV
$0
OCEA
$0
ENVB
$0
Trailing 4 Quarters Earnings -$2.2 Billion 17/17 VRTX
$2.8B
MRNA
$1.9B
CVAC
$542.7M
DNA
$89.0M
NVAX
$84.5M
KRYS
$83.8M
RETA
$22.7M
BEAM
$14.3M
NTLA
$9.1M
EDIT
$61,000
CWBR
-$0
AVRO
-$0
HEPA
-$0
RAIN
-$0
ELEV
-$0
OCEA
-$0
ENVB
-$0
Quarterly Earnings Growth 100% 4/17 CVAC
794%
RETA
362%
KRYS
182%
MRNA
100%
RAIN
84%
DNA
81%
AVRO
72%
OCEA
61%
HEPA
54%
ENVB
26%
NVAX
7%
VRTX
1%
BEAM
-1%
NTLA
-11%
ELEV
-21%
EDIT
-38%
CWBR
-59%
Annual Earnings Growth 71% 4/17 CVAC
144%
KRYS
133%
RETA
72%
MRNA
71%
RAIN
63%
BEAM
58%
HEPA
57%
ENVB
55%
OCEA
50%
DNA
21%
CWBR
1%
ELEV
-2%
NTLA
-6%
EDIT
-27%
AVRO
-59%
VRTX
-113%
NVAX
-759%
Quarterly Revenue Growth 2% 6/17 CVAC
2896%
RETA
2885%
NVAX
283%
DNA
61%
VRTX
12%
MRNA
2%
EDIT
0%
KRYS
0%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
ELEV
0%
OCEA
0%
ENVB
0%
BEAM
-17%
NTLA
-24%
Annual Revenue Growth 77% 5/17 CVAC
1284%
EDIT
613%
RETA
596%
BEAM
351%
MRNA
77%
VRTX
7%
KRYS
0%
CWBR
0%
AVRO
0%
HEPA
0%
RAIN
0%
ELEV
0%
OCEA
0%
ENVB
0%
NTLA
-18%
DNA
-27%
NVAX
-32%
Cash On Hand $1.6 Billion 2/17 VRTX
$5.2B
MRNA
$1.6B
DNA
$616.2M
CVAC
$605.3M
NVAX
$573.6M
KRYS
$374.0M
BEAM
$230.2M
NTLA
$120.5M
EDIT
$95.8M
AVRO
$90.8M
RETA
$48.8M
ELEV
$48.2M
CWBR
$6.2M
ENVB
$3.1M
HEPA
$1.5M
RAIN
$239,857
OCEA
-$0
Short Term Debt $0 12/17 NTLA
$19.2M
EDIT
$16.4M
BEAM
$12.9M
OCEA
$12.8M
NVAX
$9.7M
CVAC
$5.7M
RETA
$2.5M
HEPA
$2.2M
KRYS
$1.3M
RAIN
$806,929
AVRO
$224,000
MRNA
-$0
VRTX
-$0
CWBR
-$0
ELEV
-$0
ENVB
-$0
DNA
-$0
Long Term Debt $1.3 Billion 2/17 VRTX
$1.7B
MRNA
$1.3B
DNA
$445.6M
BEAM
$298.3M
NVAX
$223.6M
RETA
$163.5M
NTLA
$82.4M
CVAC
$38.3M
ELEV
$31.0M
EDIT
$22.1M
KRYS
$0
CWBR
$0
AVRO
$0
HEPA
$0
RAIN
$0
OCEA
$0
ENVB
$0
PE -1.00 4/17 KRYS
83.10
CVAC
6.80
AVRO
0.17
MRNA
-1.00
NVAX
-1.00
VRTX
-1.00
RETA
-1.00
EDIT
-1.00
NTLA
-1.00
CWBR
-1.00
HEPA
-1.00
BEAM
-1.00
RAIN
-1.00
ELEV
-1.00
OCEA
-1.00
ENVB
-1.00
DNA
-1.00
PS 2.31 7/17 RETA
269.17
NTLA
22.48
KRYS
18.02
VRTX
11.05
BEAM
6.77
DNA
3.25
MRNA
2.31
EDIT
1.59
NVAX
1.42
CVAC
1.26
CWBR
-1.00
AVRO
-1.00
HEPA
-1.00
RAIN
-1.00
ELEV
-1.00
OCEA
-1.00
ENVB
-1.00
PB 0.99 7/17 RETA
75.22
VRTX
7.50
KRYS
4.91
BEAM
2.99
CVAC
1.03
NTLA
1.01
MRNA
0.99
DNA
0.89
ENVB
0.77
EDIT
0.56
ELEV
0.53
CWBR
0.13
AVRO
0.06
NVAX
0.00
HEPA
0.00
RAIN
0.00
OCEA
0.00
PC 7.15 7/17 RETA
134.44
RAIN
108.73
VRTX
22.38
KRYS
11.64
BEAM
10.28
NTLA
8.04
MRNA
7.15
NVAX
2.19
HEPA
1.42
CVAC
1.36
DNA
1.15
EDIT
1.03
ENVB
0.98
ELEV
0.76
CWBR
0.19
AVRO
0.06
OCEA
-1.00
Liabilities to Equity 0.32 7/17 RETA
4.76
EDIT
0.87
DNA
0.86
ELEV
0.53
BEAM
0.48
VRTX
0.42
MRNA
0.32
CWBR
0.32
NTLA
0.22
ENVB
0.21
CVAC
0.18
KRYS
0.11
AVRO
0.04
NVAX
0.00
HEPA
0.00
RAIN
0.00
OCEA
0.00
ROA -0.14 6/17 AVRO
33%
CVAC
14%
KRYS
5%
VRTX
-2%
BEAM
-12%
MRNA
-14%
RETA
-16%
NVAX
-17%
ELEV
-39%
DNA
-44%
NTLA
-45%
EDIT
-64%
CWBR
-99%
ENVB
-206%
HEPA
-611%
OCEA
-2352%
RAIN
-4232%
ROE -0.19 10/17 HEPA
5583%
RAIN
3979%
NVAX
54%
AVRO
34%
OCEA
27%
CVAC
17%
KRYS
6%
VRTX
-3%
BEAM
-18%
MRNA
-19%
NTLA
-54%
ELEV
-60%
DNA
-82%
RETA
-94%
EDIT
-120%
CWBR
-131%
ENVB
-249%
Current Ratio 4.08 7/17 AVRO
26.32
KRYS
10.18
CVAC
6.60
ENVB
5.71
NTLA
5.57
CWBR
4.17
MRNA
4.08
VRTX
3.36
BEAM
3.08
ELEV
2.88
DNA
2.17
EDIT
2.16
RETA
1.21
HEPA
0.90
NVAX
0.76
RAIN
0.48
OCEA
0.01
Quick Ratio 0.42 13/17 KRYS
83.10
CVAC
6.80
AVRO
0.17
MRNA
-1.00
NVAX
-1.00
VRTX
-1.00
RETA
-1.00
EDIT
-1.00
NTLA
-1.00
CWBR
-1.00
HEPA
-1.00
BEAM
-1.00
RAIN
-1.00
ELEV
-1.00
OCEA
-1.00
ENVB
-1.00
DNA
-1.00
Long Term Debt to Equity 0.11 6/17 RETA}
1.87
DNA}
0.56
ELEV}
0.45
BEAM}
0.38
EDIT}
0.13
MRNA}
0.11
VRTX}
0.11
NTLA}
0.09
CVAC}
0.05
KRYS}
0.00
CWBR}
0.00
AVRO}
0.00
HEPA}
0.00
RAIN}
0.00
OCEA}
0.00
ENVB}
0.00
NVAX}
-0.42
Debt to Equity 0.11 6/17 RETA
1.90
DNA
0.56
ELEV
0.45
EDIT
0.22
BEAM
0.20
MRNA
0.11
VRTX
0.11
NTLA
0.11
CVAC
0.06
KRYS
0.00
CWBR
0.00
AVRO
0.00
ENVB
0.00
OCEA
-0.13
NVAX
-0.44
RAIN
-1.00
HEPA
-5.47
Burn Rate 41.98 1/17 MRNA
41.98
AVRO
13.22
DNA
8.30
NVAX
4.32
ELEV
3.41
BEAM
2.06
ENVB
1.49
EDIT
1.43
CWBR
1.43
NTLA
0.84
HEPA
0.28
RAIN
0.07
OCEA
0.00
RETA
-0.26
CVAC
-1.49
VRTX
-5.36
KRYS
-13.92
Cash to Cap 0.14 10/17 AVRO
17.33
CWBR
5.20
ELEV
1.32
ENVB
1.02
EDIT
0.98
DNA
0.87
CVAC
0.74
HEPA
0.70
NVAX
0.46
MRNA
0.14
NTLA
0.12
BEAM
0.10
KRYS
0.09
VRTX
0.04
RETA
0.01
RAIN
0.01
OCEA
0.00
CCR -132.08 16/17 KRYS
2.13
DNA
2.10
VRTX
1.43
ELEV
1.29
NVAX
1.20
AVRO
1.11
CVAC
1.04
BEAM
0.93
EDIT
0.89
NTLA
0.63
HEPA
0.52
ENVB
0.44
CWBR
0.42
OCEA
0.16
RETA
-0.36
MRNA
-132.08
RAIN
EV to EBITDA -163.03 17/17 KRYS}
177.39
VRTX}
101.86
CVAC}
1.05
EDIT}
-0.66
CWBR}
-1.00
AVRO}
-1.00
HEPA}
-1.00
RAIN}
-1.00
ELEV}
-1.00
OCEA}
-1.00
ENVB}
-1.00
NVAX}
-6.82
NTLA}
-7.00
DNA}
-9.74
BEAM}
-25.20
RETA}
-82.50
MRNA}
-163.03
EV to Revenue 2.25 7/17 RETA
273.97
NTLA
22.04
KRYS
16.48
VRTX
10.72
BEAM
6.57
DNA
2.47
MRNA
2.25
NVAX
1.03
EDIT
0.66
CVAC
0.66
CWBR
-1.00
AVRO
-1.00
HEPA
-1.00
RAIN
-1.00
ELEV
-1.00
OCEA
-1.00
ENVB
-1.00